P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.
Financial Results:
Procter & Gamble Health Ltd reported Revenues for Q3FY24 of ₹310.00 Crores same from ₹310.00 Crore year on year.
Total Expenses for Q3FY24 of ₹215.00 Crores up from ₹209.00 Crores year on year, a rise of 2.87%.
Consolidated Net Profit of ₹72.00 Crores down 6.49% from ₹77.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹43.42, down 6.16% from ₹46.27 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.